11/14/2024
8:29 AM | Eliem Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
11/12/2024
3:51 PM | Eliem Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/15/2024
6:08 AM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
8:53 PM | Eliem Therapeutics (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
4:21 PM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
4:47 PM | Eliem Therapeutics (Issuer)
Kaplan Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:40 PM | Eliem Therapeutics (Issuer)
Kaplan Brett (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
08/26/2024
6:07 AM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
3:23 PM | AI ETI LLC (Filed by)
Eliem Therapeutics (Subject)
| Form SC 13D/A | |
08/14/2024
5:06 AM | Eliem Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
5:10 AM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
11:15 PM | Eliem Therapeutics (Filer)
| Form EFFECT | |
07/23/2024
4:04 PM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:31 PM | Eliem Therapeutics (Filer)
| Form 424B3 | |
07/19/2024
10:12 AM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
5:11 PM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
5:14 PM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
7:45 PM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:46 PM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:42 PM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:38 PM | Eliem Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/02/2024
3:39 PM | Eliem Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/02/2024
3:01 PM | Deep Track Capital, LP (Filed by)
Eliem Therapeutics (Subject)
| Form SC 13G | |
07/01/2024
8:28 PM | Eliem Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
07/01/2024
8:29 PM | Eliem Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
5:09 PM | Eliem Therapeutics (Issuer)
Levin Andrew David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
5:14 PM | Eliem Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:23 PM | Dunn Judith (Reporting)
Eliem Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:26 PM | Eliem Therapeutics (Issuer)
Rosenberg Adam Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:09 PM | Eliem Therapeutics (Issuer)
Ratcliffe Liam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:13 PM | Eliem Therapeutics (Issuer)
Tate Simon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:00 PM | Brennan Aoife (Reporting)
Eliem Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
6:01 PM | Eliem Therapeutics (Issuer)
Thomas Stephen Basil (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
6:03 PM | Eliem Therapeutics (Issuer)
Thomas Stephen Basil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:05 PM | Brennan Aoife (Reporting)
Eliem Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:22 PM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
3:23 PM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
1:57 PM | Eliem Therapeutics (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:41 PM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
3:42 PM | Eliem Therapeutics (Filer)
| Form DEFA14A | |
06/04/2024
7:00 AM | Eliem Therapeutics (Filer)
| Form DEFM14A | |
Trump’s Back, but DC’s Coming for Your Money! (Ad) Trump's back in the White House, ready to hit the gas on America's comeback.
He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs.
But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back… Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov |
06/04/2024
7:05 AM | Eliem Therapeutics (Filer)
| Form ARS | |
05/15/2024
5:19 AM | Eliem Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
5:01 PM | Affinity Asset Advisors, LLC (Filed by)
Eliem Therapeutics (Subject)
| Form SC 13G | |
04/12/2024
5:52 PM | Eliem Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
04/11/2024
7:01 AM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:10 AM | Eliem Therapeutics (Filer)
| Form DEFA14A | |
04/08/2024
4:33 PM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:05 PM | Eliem Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2024
3:33 PM | Eliem Therapeutics (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
10:07 AM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
10:53 AM | BML Investment Partners, L.P. (Filed by)
Eliem Therapeutics (Subject)
| Form SC 13G/A | |
11/17/2023
3:30 PM | Eliem Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
